Kang, W.*, Shami, J. J. P.*, Yan, V. K. C., Ye, X., Blais, J. E., Li, X., Lee, V. H. F., Chui, C. S. L., Lai, F. T. T., Wan, E. Y. F., Wong, C. K. H., Wong, I. C. K., & Chan, E. W. (2022). Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study. Journal of Hematology & Oncology, 15(1), 66.
点击次数:
上一条:Kang, W., Huang, C., Yan, V. K. C., Wei Y., Shami, J. J. P., Li, S. T. H., Yang, Y., Ye, X., Tang, J., Lee, S. F., Lee, V. H. F., Chan, S. L., Helali, A. EI., Lam, K., Ngan, R. K. C., Wong, I. C. K., & Chan, E. W. (2024). Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thromboembolism: A population-based cohort study. Nature Communications, 15(1), 5657.
下一条:Kang, W., Peng, K., Yan, V. K. C., Al-Badriyeh, D., Lee, S. F., Yiu, E. H. H., Wei, Y., Li, S. T. H., Ye, X., Helali, A. EI., Lam, K., Lee, V. H. F., Wong, I. C. K., & Chan, E. W. (2024). Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thromboembolism: A Cost-effectiveness Analysis. Journal of Pharmaceutical Policy and Practice, 17(1), 2375269.
